nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftriaxone—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Ceftriaxone—Flushing—Etoposide—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Ceftriaxone—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Ceftriaxone—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Ceftriaxone—Hypertonia—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Ceftriaxone—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Ceftriaxone—Chills—Etoposide—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Ceftriaxone—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Ceftriaxone—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.001	0.001	CcSEcCtD
Ceftriaxone—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.001	0.001	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.000999	0.000999	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000997	0.000997	CcSEcCtD
Ceftriaxone—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000995	0.000995	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000994	0.000994	CcSEcCtD
Ceftriaxone—Oedema—Vincristine—peripheral nervous system neoplasm	0.000994	0.000994	CcSEcCtD
Ceftriaxone—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00099	0.00099	CcSEcCtD
Ceftriaxone—Infection—Vincristine—peripheral nervous system neoplasm	0.000987	0.000987	CcSEcCtD
Ceftriaxone—Phlebitis—Doxorubicin—peripheral nervous system neoplasm	0.000986	0.000986	CcSEcCtD
Ceftriaxone—Thrombophlebitis—Doxorubicin—peripheral nervous system neoplasm	0.000982	0.000982	CcSEcCtD
Ceftriaxone—Dermatitis exfoliative—Epirubicin—peripheral nervous system neoplasm	0.000973	0.000973	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000973	0.000973	CcSEcCtD
Ceftriaxone—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000972	0.000972	CcSEcCtD
Ceftriaxone—Malaise—Cisplatin—peripheral nervous system neoplasm	0.000971	0.000971	CcSEcCtD
Ceftriaxone—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000971	0.000971	CcSEcCtD
Ceftriaxone—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.000966	0.000966	CcSEcCtD
Ceftriaxone—Renal impairment—Epirubicin—peripheral nervous system neoplasm	0.000965	0.000965	CcSEcCtD
Ceftriaxone—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000964	0.000964	CcSEcCtD
Ceftriaxone—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000963	0.000963	CcSEcCtD
Ceftriaxone—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000963	0.000963	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000961	0.000961	CcSEcCtD
Ceftriaxone—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000951	0.000951	CcSEcCtD
Ceftriaxone—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000951	0.000951	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.000949	0.000949	CcSEcCtD
Ceftriaxone—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000939	0.000939	CcSEcCtD
Ceftriaxone—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000933	0.000933	CcSEcCtD
Ceftriaxone—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000931	0.000931	CcSEcCtD
Ceftriaxone—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000931	0.000931	CcSEcCtD
Ceftriaxone—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000926	0.000926	CcSEcCtD
Ceftriaxone—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000919	0.000919	CcSEcCtD
Ceftriaxone—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000917	0.000917	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000915	0.000915	CcSEcCtD
Ceftriaxone—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000912	0.000912	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00091	0.00091	CcSEcCtD
Ceftriaxone—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000908	0.000908	CcSEcCtD
Ceftriaxone—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000907	0.000907	CcSEcCtD
Ceftriaxone—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000906	0.000906	CcSEcCtD
Ceftriaxone—Dermatitis exfoliative—Doxorubicin—peripheral nervous system neoplasm	0.000901	0.000901	CcSEcCtD
Ceftriaxone—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.0009	0.0009	CcSEcCtD
Ceftriaxone—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.0009	0.0009	CcSEcCtD
Ceftriaxone—Renal impairment—Doxorubicin—peripheral nervous system neoplasm	0.000893	0.000893	CcSEcCtD
Ceftriaxone—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000893	0.000893	CcSEcCtD
Ceftriaxone—Malaise—Etoposide—peripheral nervous system neoplasm	0.00089	0.00089	CcSEcCtD
Ceftriaxone—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000883	0.000883	CcSEcCtD
Ceftriaxone—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000882	0.000882	CcSEcCtD
Ceftriaxone—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000879	0.000879	CcSEcCtD
Ceftriaxone—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000879	0.000879	CcSEcCtD
Ceftriaxone—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000879	0.000879	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000879	0.000879	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000878	0.000878	CcSEcCtD
Ceftriaxone—Infection—Cisplatin—peripheral nervous system neoplasm	0.000873	0.000873	CcSEcCtD
Ceftriaxone—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000872	0.000872	CcSEcCtD
Ceftriaxone—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000865	0.000865	CcSEcCtD
Ceftriaxone—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000865	0.000865	CcSEcCtD
Ceftriaxone—Rash—Topotecan—peripheral nervous system neoplasm	0.000865	0.000865	CcSEcCtD
Ceftriaxone—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000864	0.000864	CcSEcCtD
Ceftriaxone—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000864	0.000864	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000861	0.000861	CcSEcCtD
Ceftriaxone—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.00086	0.00086	CcSEcCtD
Ceftriaxone—Headache—Topotecan—peripheral nervous system neoplasm	0.00086	0.00086	CcSEcCtD
Ceftriaxone—Rash—Tretinoin—peripheral nervous system neoplasm	0.000858	0.000858	CcSEcCtD
Ceftriaxone—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000858	0.000858	CcSEcCtD
Ceftriaxone—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000857	0.000857	CcSEcCtD
Ceftriaxone—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000857	0.000857	CcSEcCtD
Ceftriaxone—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000855	0.000855	CcSEcCtD
Ceftriaxone—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000854	0.000854	CcSEcCtD
Ceftriaxone—Headache—Tretinoin—peripheral nervous system neoplasm	0.000853	0.000853	CcSEcCtD
Ceftriaxone—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000853	0.000853	CcSEcCtD
Ceftriaxone—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00085	0.00085	CcSEcCtD
Ceftriaxone—Pain—Vincristine—peripheral nervous system neoplasm	0.00085	0.00085	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00085	0.00085	CcSEcCtD
Ceftriaxone—Rash—Melphalan—peripheral nervous system neoplasm	0.000847	0.000847	CcSEcCtD
Ceftriaxone—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000846	0.000846	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000844	0.000844	CcSEcCtD
Ceftriaxone—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000839	0.000839	CcSEcCtD
Ceftriaxone—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00083	0.00083	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000827	0.000827	CcSEcCtD
Ceftriaxone—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000827	0.000827	CcSEcCtD
Ceftriaxone—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00082	0.00082	CcSEcCtD
Ceftriaxone—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000819	0.000819	CcSEcCtD
Ceftriaxone—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000815	0.000815	CcSEcCtD
Ceftriaxone—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000815	0.000815	CcSEcCtD
Ceftriaxone—Nausea—Topotecan—peripheral nervous system neoplasm	0.000815	0.000815	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000813	0.000813	CcSEcCtD
Ceftriaxone—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000808	0.000808	CcSEcCtD
Ceftriaxone—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000808	0.000808	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000805	0.000805	CcSEcCtD
Ceftriaxone—Infection—Etoposide—peripheral nervous system neoplasm	0.0008	0.0008	CcSEcCtD
Ceftriaxone—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000799	0.000799	CcSEcCtD
Ceftriaxone—Nausea—Melphalan—peripheral nervous system neoplasm	0.000798	0.000798	CcSEcCtD
Ceftriaxone—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000796	0.000796	CcSEcCtD
Ceftriaxone—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000789	0.000789	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000788	0.000788	CcSEcCtD
Ceftriaxone—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000786	0.000786	CcSEcCtD
Ceftriaxone—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000786	0.000786	CcSEcCtD
Ceftriaxone—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000786	0.000786	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000778	0.000778	CcSEcCtD
Ceftriaxone—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000778	0.000778	CcSEcCtD
Ceftriaxone—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000776	0.000776	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000765	0.000765	CcSEcCtD
Ceftriaxone—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000765	0.000765	CcSEcCtD
Ceftriaxone—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000761	0.000761	CcSEcCtD
Ceftriaxone—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00076	0.00076	CcSEcCtD
Ceftriaxone—Pain—Cisplatin—peripheral nervous system neoplasm	0.000752	0.000752	CcSEcCtD
Ceftriaxone—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000742	0.000742	CcSEcCtD
Ceftriaxone—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000732	0.000732	CcSEcCtD
Ceftriaxone—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00073	0.00073	CcSEcCtD
Ceftriaxone—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000727	0.000727	CcSEcCtD
Ceftriaxone—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000724	0.000724	CcSEcCtD
Ceftriaxone—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000723	0.000723	CcSEcCtD
Ceftriaxone—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.00072	0.00072	CcSEcCtD
Ceftriaxone—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000707	0.000707	CcSEcCtD
Ceftriaxone—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000706	0.000706	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000702	0.000702	CcSEcCtD
Ceftriaxone—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000701	0.000701	CcSEcCtD
Ceftriaxone—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000696	0.000696	CcSEcCtD
Ceftriaxone—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000695	0.000695	CcSEcCtD
Ceftriaxone—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.00069	0.00069	CcSEcCtD
Ceftriaxone—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.00069	0.00069	CcSEcCtD
Ceftriaxone—Pain—Etoposide—peripheral nervous system neoplasm	0.000689	0.000689	CcSEcCtD
Ceftriaxone—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000687	0.000687	CcSEcCtD
Ceftriaxone—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000682	0.000682	CcSEcCtD
Ceftriaxone—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00068	0.00068	CcSEcCtD
Ceftriaxone—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000675	0.000675	CcSEcCtD
Ceftriaxone—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000668	0.000668	CcSEcCtD
Ceftriaxone—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000664	0.000664	CcSEcCtD
Ceftriaxone—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000661	0.000661	CcSEcCtD
Ceftriaxone—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.00066	0.00066	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000658	0.000658	CcSEcCtD
Ceftriaxone—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000657	0.000657	CcSEcCtD
Ceftriaxone—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000656	0.000656	CcSEcCtD
Ceftriaxone—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00065	0.00065	CcSEcCtD
Ceftriaxone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00065	0.00065	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000649	0.000649	CcSEcCtD
Ceftriaxone—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000648	0.000648	CcSEcCtD
Ceftriaxone—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000646	0.000646	CcSEcCtD
Ceftriaxone—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000644	0.000644	CcSEcCtD
Ceftriaxone—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00064	0.00064	CcSEcCtD
Ceftriaxone—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000639	0.000639	CcSEcCtD
Ceftriaxone—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000638	0.000638	CcSEcCtD
Ceftriaxone—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000638	0.000638	CcSEcCtD
Ceftriaxone—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000637	0.000637	CcSEcCtD
Ceftriaxone—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000637	0.000637	CcSEcCtD
Ceftriaxone—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000635	0.000635	CcSEcCtD
Ceftriaxone—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000632	0.000632	CcSEcCtD
Ceftriaxone—Rash—Vincristine—peripheral nervous system neoplasm	0.000627	0.000627	CcSEcCtD
Ceftriaxone—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000626	0.000626	CcSEcCtD
Ceftriaxone—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000624	0.000624	CcSEcCtD
Ceftriaxone—Headache—Vincristine—peripheral nervous system neoplasm	0.000623	0.000623	CcSEcCtD
Ceftriaxone—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000618	0.000618	CcSEcCtD
Ceftriaxone—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000613	0.000613	CcSEcCtD
Ceftriaxone—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000611	0.000611	CcSEcCtD
Ceftriaxone—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000601	0.000601	CcSEcCtD
Ceftriaxone—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000601	0.000601	CcSEcCtD
Ceftriaxone—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000593	0.000593	CcSEcCtD
Ceftriaxone—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000591	0.000591	CcSEcCtD
Ceftriaxone—Nausea—Vincristine—peripheral nervous system neoplasm	0.00059	0.00059	CcSEcCtD
Ceftriaxone—Flushing—Epirubicin—peripheral nervous system neoplasm	0.00059	0.00059	CcSEcCtD
Ceftriaxone—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000588	0.000588	CcSEcCtD
Ceftriaxone—Chills—Epirubicin—peripheral nervous system neoplasm	0.00057	0.00057	CcSEcCtD
Ceftriaxone—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00057	0.00057	CcSEcCtD
Ceftriaxone—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000559	0.000559	CcSEcCtD
Ceftriaxone—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000556	0.000556	CcSEcCtD
Ceftriaxone—Rash—Cisplatin—peripheral nervous system neoplasm	0.000554	0.000554	CcSEcCtD
Ceftriaxone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000554	0.000554	CcSEcCtD
Ceftriaxone—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000551	0.000551	CcSEcCtD
Ceftriaxone—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000546	0.000546	CcSEcCtD
Ceftriaxone—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000545	0.000545	CcSEcCtD
Ceftriaxone—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000542	0.000542	CcSEcCtD
Ceftriaxone—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000532	0.000532	CcSEcCtD
Ceftriaxone—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000527	0.000527	CcSEcCtD
Ceftriaxone—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000522	0.000522	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000513	0.000513	CcSEcCtD
Ceftriaxone—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000512	0.000512	CcSEcCtD
Ceftriaxone—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000511	0.000511	CcSEcCtD
Ceftriaxone—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000508	0.000508	CcSEcCtD
Ceftriaxone—Rash—Etoposide—peripheral nervous system neoplasm	0.000508	0.000508	CcSEcCtD
Ceftriaxone—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000507	0.000507	CcSEcCtD
Ceftriaxone—Headache—Etoposide—peripheral nervous system neoplasm	0.000504	0.000504	CcSEcCtD
Ceftriaxone—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000504	0.000504	CcSEcCtD
Ceftriaxone—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000501	0.000501	CcSEcCtD
Ceftriaxone—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000499	0.000499	CcSEcCtD
Ceftriaxone—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000495	0.000495	CcSEcCtD
Ceftriaxone—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000489	0.000489	CcSEcCtD
Ceftriaxone—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000479	0.000479	CcSEcCtD
Ceftriaxone—Nausea—Etoposide—peripheral nervous system neoplasm	0.000478	0.000478	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000475	0.000475	CcSEcCtD
Ceftriaxone—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000473	0.000473	CcSEcCtD
Ceftriaxone—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.00047	0.00047	CcSEcCtD
Ceftriaxone—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000465	0.000465	CcSEcCtD
Ceftriaxone—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000461	0.000461	CcSEcCtD
Ceftriaxone—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000458	0.000458	CcSEcCtD
Ceftriaxone—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000452	0.000452	CcSEcCtD
Ceftriaxone—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000451	0.000451	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000451	0.000451	CcSEcCtD
Ceftriaxone—Infection—Epirubicin—peripheral nervous system neoplasm	0.000448	0.000448	CcSEcCtD
Ceftriaxone—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000443	0.000443	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000442	0.000442	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000436	0.000436	CcSEcCtD
Ceftriaxone—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00043	0.00043	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000418	0.000418	CcSEcCtD
Ceftriaxone—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000418	0.000418	CcSEcCtD
Ceftriaxone—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000415	0.000415	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000409	0.000409	CcSEcCtD
Ceftriaxone—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000405	0.000405	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000404	0.000404	CcSEcCtD
Ceftriaxone—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000397	0.000397	CcSEcCtD
Ceftriaxone—Pain—Epirubicin—peripheral nervous system neoplasm	0.000386	0.000386	CcSEcCtD
Ceftriaxone—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000375	0.000375	CcSEcCtD
Ceftriaxone—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000372	0.000372	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000369	0.000369	CcSEcCtD
Ceftriaxone—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000368	0.000368	CcSEcCtD
Ceftriaxone—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000359	0.000359	CcSEcCtD
Ceftriaxone—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000357	0.000357	CcSEcCtD
Ceftriaxone—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000357	0.000357	CcSEcCtD
Ceftriaxone—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000357	0.000357	CcSEcCtD
Ceftriaxone—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000344	0.000344	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000342	0.000342	CcSEcCtD
Ceftriaxone—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000333	0.000333	CcSEcCtD
Ceftriaxone—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.000332	CcSEcCtD
Ceftriaxone—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.00033	0.00033	CcSEcCtD
Ceftriaxone—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.00033	0.00033	CcSEcCtD
Ceftriaxone—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000319	0.000319	CcSEcCtD
Ceftriaxone—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000309	0.000309	CcSEcCtD
Ceftriaxone—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000308	0.000308	CcSEcCtD
Ceftriaxone—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000298	CcSEcCtD
Ceftriaxone—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.000295	CcSEcCtD
Ceftriaxone—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000287	CcSEcCtD
Ceftriaxone—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.000286	CcSEcCtD
Ceftriaxone—Rash—Epirubicin—peripheral nervous system neoplasm	0.000285	0.000285	CcSEcCtD
Ceftriaxone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000284	0.000284	CcSEcCtD
Ceftriaxone—Headache—Epirubicin—peripheral nervous system neoplasm	0.000283	0.000283	CcSEcCtD
Ceftriaxone—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000276	CcSEcCtD
Ceftriaxone—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000268	0.000268	CcSEcCtD
Ceftriaxone—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.000266	CcSEcCtD
Ceftriaxone—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.000263	CcSEcCtD
Ceftriaxone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.000263	CcSEcCtD
Ceftriaxone—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.000262	CcSEcCtD
Ceftriaxone—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000248	CcSEcCtD
